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Abstract
The EFSA Scientiﬁc Committee addressed in this document the peculiarities related to the genotoxicity
assessment of chemical mixtures. The EFSA Scientiﬁc Committee suggests that ﬁrst a mixture should
be chemically characterised as far as possible. Although the characterisation of mixtures is relevant
also for other toxicity aspects, it is particularly signiﬁcant for the assessment of genotoxicity. If a
mixture contains one or more chemical substances that are individually assessed to be genotoxic
in vivo via a relevant route of administration, the mixture raises concern for genotoxicity. If a fully
chemically deﬁned mixture does not contain genotoxic chemical substances, the mixture is of no
concern with respect to genotoxicity. If a mixture contains a fraction of chemical substances that have
not been chemically identiﬁed, experimental testing of the unidentiﬁed fraction should be considered
as the ﬁrst option or, if this is not feasible, testing of the whole mixture should be undertaken. If
testing of these fraction(s) or of the whole mixture in an adequately performed set of in vitro assays
provides clearly negative results, the mixture does not raise concern for genotoxicity. If in vitro testing
provides one or more positive results, an in vivo follow-up study should be considered. For negative
results in the in vivo follow-up test(s), the possible limitations of in vivo testing should be weighed in
an uncertainty analysis before reaching a conclusion of no concern with respect to genotoxicity. For
positive results in the in vivo follow-up test(s), it can be concluded that the mixture does raise a
concern about genotoxicity.
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1. Introduction
1.1. Background and Terms of Reference as provided by EFSA
Human and ecological risk assessment of combined exposure to multiple chemicals (‘chemical
mixtures’) poses a number of challenges to scientists, risk assessors and risk managers, particularly
because of the complexity of the problem formulation, the almost inﬁnite number of possible combinations
of chemicals and the large amount of data needed to describe the toxicological proﬁles and exposure
patterns of these chemicals in humans and species present in the environment. The development of
harmonised methodologies for combined exposure to multiple chemicals in all areas of EFSA’s remit has
been identiﬁed by EFSA’s Scientiﬁc Committee as a key priority area. Some EFSA panels and units have
initiated activities to support harmonisation of risk assessment methods for both human health and
ecology. In particular, the Scientiﬁc Committee initiated in 2016 an activity to develop guidance on
harmonised risk assessment methodologies for human health, animal health and ecological risk assessment
of combined exposure to multiple chemicals. Work is ongoing and a draft guidance has been published for
public consultation in summer 2018 (https://www.efsa.europa.eu/en/consultations/call/180626-0).
Finalisation of the guidance is expected in spring 2019.
At present, information on the genotoxicity of a chemical drives the type of the assessment in
human risk assessment: if the chemical is not genotoxic, a health-based guidance value is usually set,
whilst if there is an unavoidable chemical that is a genotoxic carcinogen, the Margin of Exposure
approach is usually applied (EFSA, 2005). With respect to assessing the genotoxicity of mixtures,
speciﬁc additional considerations might be needed, e.g. when it is not possible to fully characterise a
complex mixture due to analytical problems.
Different areas within EFSA’s remit have different data requirements in relation to the assessment
of mixtures:
• Plant protection products:
 Regulation (EC) No. 1107/2009 on the placing of plant protection products on the market
requires that ‘interaction between the active substance, safeners, synergists and
coformulants shall be taken into account’ in the evaluation and authorisation of plant
protection products (Article 29).
 Commission Regulation (EU) No. 283/2013, setting out the data requirements for active
substances in plant protection products, in accordance with Regulation (EC) No. 1107/
2009 of the European Parliament further requests:
o a risk assessment of consumer exposure, including, when relevant, a cumulative risk
assessment deriving from exposure to more than one active substance;
o an estimation of the exposure to operators, workers, residents and bystanders
including, when relevant, the cumulative exposure to more than one active substance.
 Commission Regulation (EU) No. 284/2013, setting out the data requirements for plant
protection products, in accordance with Regulation (EC) No. 1107/2009 of the European
Parliament further requests ‘any information on potentially unacceptable effects of the
plant protection product on the environment, on plants and plant products shall be
included as well as known and expected cumulative and synergistic effects’.
 Regulation (EC) No. 396/2005 on maximum residue levels (MRLs) of pesticides in or on
food and feed of plant and animal origin requires cumulative risk assessment for pesticides
to be performed. Recital 6 states: ‘It is also important to carry out further work to develop
a methodology to take into account cumulative and synergistic effects’. It further speciﬁes
that MRLs should be set in ‘view of human exposure to combinations of active substances
and their cumulative and possible aggregate and synergistic effects on human health’.
• Feed additives:
 Regulation (EC) No. 429/2008 on the assessment and authorisation of feed additives
explicitly addresses risks that may arise from combined exposures if feed additives placed
on the market contain more than one (active) ingredient. Annex II lists the requirement
that ‘when an additive has multiple components, each one may be separately assessed for
consumer safety and then consideration given to the cumulative effect (when it can be
Genotoxicity assessment of chemical mixtures
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shown that there are no interactions between the components). Alternatively, the
complete mixture shall be assessed’.
• Smoke ﬂavourings:
 Regulation (EC) No. 2065/2003 on the assessment and authorisation of smoke ﬂavourings
used or intended for use in or on food. Annex II includes the information necessary for the
scientiﬁc evaluation of primary products, i.e. primary smoke condensates and primary tar
fractions produced by controlled thermal degradation of wood in a limited supply of
oxygen (pyrolysis), all of these being complex chemical mixtures. In accordance with this
Annex, the toxicological data requirements should follow the advice of the Scientiﬁc
Committee on Food, given in its report of 25 June 1993, according to which relevant data
should be generated on the whole mixture.
Legislation in relation to food additives, food contact materials and food contaminants does not
have speciﬁc provisions requiring risk assessment of mixtures. However, this does not imply that
mixtures are never addressed. For example, in Regulation (EC) No. 1881/2006, the setting of
maximum levels for certain contaminants in foodstuffs (e.g. dioxins, polycyclic aromatic hydrocarbons
and a number of mycotoxins) are underpinned by a mixtures risk assessment.
Given this background, the SC discussed and agreed to develop a statement clarifying how to
perform genotoxicity assessment of chemical mixtures with cross-reference to previous EFSA guidance
documents.
1.1.1. Terms of Reference
Starting from the basic deﬁnition of chemical mixtures as presented in the ‘Guidance on harmonised
risk assessment methodologies for human health, animal health and ecological risk assessment of
combined exposure to multiple chemicals’, the SC should develop a statement that:
• clariﬁes the peculiarities related to genotoxicity assessment of mixtures, i.e. identiﬁcation of
speciﬁc additional considerations and their triggers;
• addresses both component-based and whole mixture approaches.
Consideration from the different areas within EFSA’s remit should be given to explore the feasibility
and spectrum of applications of the proposed approaches for human health risk assessment.
1.2. Interpretation of the Terms of Reference and general
considerations
A general guidance document addressing harmonised methods for risk assessment of combined
exposure to multiple chemicals for all relevant areas within EFSA’s remit, including human health and
environmental aspects, has been developed in parallel to this statement and will be published in spring
2019 (2018 draft published for public consultation available at https://www.efsa.europa.eu/en/consulta
tions/call/180626-0). Those risk assessment principles are not repeated in this document.
This statement addresses primarily speciﬁc issues related to hazard identiﬁcation of genotoxicity of
mixtures and provides a general framework for the assessment of the genotoxic hazard of chemical
mixtures. For all other aspects of risk assessment of mixtures, the reader is referred to the guidance
document on combined exposure to multiple chemicals in preparation (expected to be published in
spring 2019).
It is also not in the scope of this statement to provide guidance on the assays to be applied for
genotoxicity testing of chemical mixtures. However the Scientiﬁc Committee recommends to follow the
opinion on genotoxicity testing strategies (EFSA, 2011) and the statement on ‘Clariﬁcation of some
aspects related to genotoxicity assessment’ (EFSA, 2017).
Based on the guidance on mixtures, a differentiation is made between mixtures that are chemically
fully deﬁned or characterised and mixtures in which not all of the components have been
characterised. These two situations are considered separately in this statement.
Examples of chemically fully deﬁned mixtures are a mixture produced by adding together separate
chemical substances, a chemically well characterised mixture produced by a controlled process, or a
group of separate chemical substances to which combined exposure can occur, such as a group of
individual pesticides or food additives. The Scientiﬁc Committee notes that the term ‘chemically fully
deﬁned’ does not mean that all chemical components have to be known. As with individual chemical
Genotoxicity assessment of chemical mixtures
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substances, which in practice are never 100% pure, the acceptable impurities in a chemical mixture
are usually deﬁned in the speciﬁcations.
Considering the wide range of mixtures to be expected, it is not possible to establish a certain
generic ‘cut-off’ value, i.e. the percentage of unidentiﬁed chemical substances in a mixture considered
acceptable, without further testing (not calling for a whole mixture testing or testing of the respective
fraction). The Scientiﬁc Committee, however, stresses that state-of-the-art analytical methodologies
should be applied. Taking into account the nature of the mixture (e.g. chemical classes of the
constituents or its production process), the employed analytical techniques should be able to detect
and to quantify constituents at limits of detection (LOD) and limits of quantiﬁcation (LOQ), respectively,
generally accepted in routine analysis. So, an accepted analytical ‘cut-off’ value for a mixture of
volatiles directly amenable to gas chromatography (GS) analysis may differ substantially from that for a
mixture of non-volatiles from different chemical classes analysed via liquid chromatography/mass
spectrometry (LC/MS). Therefore, in the different areas within EFSA’s remit, speciﬁc considerations are
needed (e.g. for botanicals, novel foods, pesticides or food and feed additives).
The Scientiﬁc Committee notes that it may be possible to deviate from approaches proposed in the
present statement, if it can be scientiﬁcally justiﬁed.
Deﬁnitions of the terms used in this statement are given in the glossary in the end of this
document.
2. Assessment
2.1. Chemical characterisation of mixtures
The demonstration of the identity and stability (batch-to-batch variability as well as stability over
time) of a mixture is always required to ensure that the mixture tested is representative of the mixture
to be placed on the market (e.g. for regulated products) or representative for mixtures present in the
environment or food (e.g. contaminants).
2.1.1. Qualitative and quantitative analysis of the composition of a mixture
The ﬁrst step must be to characterise the mixture as fully as possible. Compositional data are required
for qualitative and quantitative analysis of a mixture. Although the characterisation of mixtures is relevant
also for other toxicity aspects, it is particularly important for the assessment of genotoxicity.
Chemically fully deﬁned mixtures
For mixtures of chemically deﬁned substances, information on the identities and the relative ratios
should be provided. For mixtures prepared by adding individual chemical substances, the decision on
which degree of ‘purity’ of the individual components can be considered sufﬁcient does not differ from
the decision to be taken for individual chemical substances. This may also depend on speciﬁc sources
and the production process of the mixture.
Mixtures containing a substantial fraction of unidentiﬁed components
For mixtures for which not all components have been chemically fully identiﬁed, a quantitative
characterisation of the main constituents should be performed, at least for sum parameters (e.g. total
phenols, total acids, total protein or reducing sugars). The percentage of unidentiﬁed components
should be indicated and should be as low as possible. Therefore, the analytical methods employed to
characterise the mixture should at least be able to cover the type and the expected analytes (i.e.
chemical substances that, based on knowledge of the source and the production/formation of the
mixtures, are expected to be potentially present).
2.2. Genotoxicity assessment of chemically fully deﬁned mixtures
For chemically fully deﬁned mixtures, the Scientiﬁc Committee recommends applying a component-
based approach, i.e. assessing all components individually using all available information including read
across and quantitative structure–activity relationship (QSAR) considerations about their genotoxic
potential, following the Scientiﬁc Committee guidance (EFSA, 2011, 2017). This means that for
regulated products, conclusions on genotoxicity will be required for all components or at least for
representative chemical substances for mixtures containing structurally related substances. For
chemically fully deﬁned mixtures made of closely related molecules, for which no divergent genotoxic
Genotoxicity assessment of chemical mixtures
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potentials are anticipated based on structureactivity relationship (SAR) considerations, the testing of
the whole mixtures may also be acceptable, as no dilution of the effect is expected when all
components in a mixture share the same properties. However, when dealing with mixtures of structural
isomers, the genotoxic potential might differ between the structural isomers and this should be
addressed case by case.
If such a mixture contains one or more chemical substances that are assessed to be genotoxic
in vivo via a relevant route of administration (i.e. in most cases after oral exposure), the whole mixture
raises concern for genotoxicity. The risk to human health related to this identiﬁed hazard may need to
be taken into account in the overall risk assessment.
For mixtures that contain individual components indicating a potential concern for genotoxicity but
for which the data available are not sufﬁcient to conclude on genotoxicity, e.g. positive results in
in vitro genotoxicity tests of an individual component without an appropriate in vivo follow-up test,
additional data would be needed to complete an assessment, following the Scientiﬁc Committee
guidance (EFSA, 2011, 2017).
When the mixture contains structurally related chemical substances, a representative chemical
substance (ideally expected to have the highest DNA reactivity among the structurally related
substances, based on expert judgement), could be further tested and used as an indicator substance
for all structurally related chemical substances. This should be carried out as for individual chemical
substances following the Scientiﬁc Committee guidance (EFSA, 2011, 2017). If a fraction or a
representative chemical substance of the mixture is tested, the reasons for the choice need to be
explained.
The Scientiﬁc Committee reiterates its earlier statement that chemical substances that are both
genotoxic and carcinogenic should not be deliberately added to foods or used earlier in the food chain.
In certain cases, i.e. unavoidable contaminants and impurities, it might be possible to conclude that
human exposure is likely to be of low concern from a public health perspective. Such a conclusion may
be reached based on a Margin of Exposure (MOE) approach (EFSA, 2005, 2012a) when respective
carcinogenicity data are available, either for the genotoxicant itself or for a structurally closely related
chemical substance. For details on the application of the MOE approach for mixtures, the reader is
referred to the guidance document on combined exposure to multiple chemicals under development
(EFSA in preparation, expected to be published in spring 2019). The Scientiﬁc Committee notes that in
the scientiﬁc community there is, as yet, no consensus on whether and how a MOE approach could be
applied to genotoxicity data alone (in the absence of relevant carcinogenicity data).
If no relevant carcinogenicity data are available and the estimated exposure to the chemical
substance is very low, it might be possible to apply the Threshold of Toxicological Concern (TTC) concept
(EFSA, 2012b; and EFSA ongoing revision of TTC guidance, expected to be published in spring 2019).
2.3. Genotoxicity assessment of mixtures containing a substantial
fraction of unidentiﬁed components
If a mixture contains, besides chemically identiﬁed substances, a substantial1 fraction of chemical
substances that have not been chemically characterised, the Scientiﬁc Committee recommends that
ﬁrst the chemically deﬁned substances be assessed individually for their potential genotoxicity, using all
available information, including read across and QSAR considerations about their genotoxic potential,
following the Scientiﬁc Committee guidance (EFSA, 2011, 2017). This means that for regulated
products, a conclusion on genotoxicity will be required for all identiﬁed components or at least for
representative chemical substances for mixtures containing structurally related substances. As
described in Section 2.2, if the mixture contains one or more chemical substances that are evaluated
to be genotoxic in vivo via a relevant route of administration, the whole mixture raises concern about
genotoxicity.
As already mentioned in Section 2.2, for mixtures that contain individual components that may
indicate a potential concern for genotoxicity but for which the data available are not sufﬁcient to
conclude on genotoxicity, e.g. positive results in in vitro genotoxicity tests of an individual component,
additional data would be needed to complete an assessment (EFSA, 2011, 2017).
If none of the identiﬁed chemical substances in a mixture raises concern for genotoxicity, the
genotoxic potential of the unidentiﬁed fraction should also be evaluated to complete the assessment of
1 A general deﬁnition of ‘substantial’ is not possible as it depends on several factors such as the nature of the source and the
production/formation process and needs to be decided on a case-by-case basis.
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the mixture. Experimental testing of the unidentiﬁed fraction should be considered as the ﬁrst option
or, if this is not feasible and a scientiﬁc justiﬁcation is provided, testing of the whole mixture should be
undertaken. Further fractionation of the test material could be considered case by case to remove
inert, toxicologically irrelevant components from the mixture (e.g. high-molecular-weight polymers) to
minimise the dilution of the components of interest in the tested sample, or to remove highly toxic
components (e.g. surface active substances) that may prevent testing adequately high doses of the
mixture because of overt toxicity. Moreover, if either the starting material used or the production
process indicates the possible presence of genotoxicants in the unidentiﬁed fraction of the mixture, an
attempt should be made to isolate and test the fraction of concern as such, if it is not possible to
chemically identify and quantify the substance.
The testing strategy for a whole mixture or its fraction(s) should follow the Scientiﬁc Committee
testing strategy guidance for individual chemical substances (EFSA, 2011, 2017). However, as
mentioned in the OECD (2015, 2016a, 2016c; Test Nos. 473, 476, 487, 490) (in vitro testing): ‘When
the test chemical is not of deﬁned composition, e.g. substance of unknown or variable composition,
complex reaction products or biological materials (i.e. UVCBs), environmental extracts, etc., the top
concentration may need to be higher (e.g. 5 mg/mL), in the absence of sufﬁcient cytotoxicity, to
increase the concentration of each of the components’.
If testing of the whole mixture or its fraction(s) in an adequately performed set of in vitro assays
(e.g. (OECD, 1997) Test No. 471 and (OECD, 2016e) Test No. 487) following the Scientiﬁc Committee
testing strategy (EFSA, 2011, 2017) provides clearly negative results, the mixture could be considered
as of no concern with respect to genotoxicity and no further testing is recommended.
If testing of the whole mixture or its fraction(s) in an adequately performed set of in vitro assays
provides one or more positive results, in vivo follow-up testing should be considered to assess the
relevance of these ﬁndings for risk assessment. The follow-up study should be tailored case by case
based on the activity proﬁle/mode of action observed in vitro, following the Scientiﬁc Committee
genotoxicity testing strategy (EFSA, 2011, 2017), and taking into account any other relevant
information (e.g. on source and chemical characteristics of the mixture).
If the in vivo testing of an in vitro positive mixture provides negative results, the relevance of the
ﬁndings obtained in the in vivo follow-up tests will depend on the genetic effect assessed (i.e. gene
mutations, structural or numerical chromosomal aberrations), the test protocol applied (route of
exposure, tissues, etc.) and expert judgement on the reliability of the results obtained (including
consideration of target tissue exposure).
In some instances it can be anticipated that negative results in the follow-up tests can support,
with sufﬁcient conﬁdence, a lack of concern about the in vivo genotoxicity of the mixture. For
example, for a mixture that is directly clastogenic in vitro, a robust assessment in vivo could be
performed by applying a mammalian alkaline comet assay (OECD (2016d) Test No. 489) to several
tissues, including the site of ﬁrst contact, to animals in which the mixture was administered orally. For
other effects, such as induction of gene mutations and/or clastogenicity in vitro following metabolic
activation, the assessment of systemic genotoxic effects (e.g. in the liver or bone marrow) may be
limited by the fact that target tissue exposure cannot be demonstrated, as any toxic effect elicited in
the target tissue by the mixture cannot be unequivocally attributed to the (in vitro) genotoxic
component. In this scenario, the conclusion drawn would have a higher uncertainty.
Another relevant concern is the follow-up testing of in vitro aneugens. At present, the only
validated methodology to assess aneugenicity is the rodent bone marrow micronucleus assay (OECD
(2016b) Test No. 474). In this scenario, the lack of information on target tissue exposure may be a
critical limitation, also because of the possibility of effects at the site of ﬁrst contact, in which local
concentrations may be higher than in the bone marrow and aneugenic effects cannot be investigated
reliably because micronucleus assays in tissues other than bone marrow or peripheral blood are not
sufﬁciently validated as yet.
So, for negative results in the in vivo follow-up study, the possible limitations of in vivo testing
should be weighed in an uncertainty analysis before reaching a conclusion of no concern with respect
to genotoxicity of complex mixtures that provided positive in vitro results.
Conversely, for positive results in the in vivo follow-up tests, it can be concluded that the mixture
does raise a concern about genotoxicity. In this scenario, it may also be prudent to consider in the
overall assessment positive test results in vivo that are obtained under conditions associated with overt
toxicity, which are usually considered of limited relevance, as it cannot be decided whether the
observed genotoxic effects are secondary due to cytotoxicity. The underlying cytotoxicity (organ
toxicity) could be elicited by the same or different components of the mixture.
Genotoxicity assessment of chemical mixtures
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3. Conclusions
In this statement, a differentiation is made between mixtures that are chemically fully deﬁned or
characterised and mixtures in which not all the components have been characterised. The Scientiﬁc
Committee however notes that the term ‘chemically fully deﬁned’ does not mean that all chemical
components have to be known. As with individual chemical substances, which in practice are never
100% pure, the acceptable impurities in a chemical mixture are usually deﬁned in the speciﬁcations
based on expert judgement:
• The ﬁrst step must be to characterise the mixture as fully as possible. Compositional data are
required for qualitative and quantitative analysis of a mixture.
• The demonstration of the identity and stability of a mixture is always required to ensure that
the mixture tested is representative of the mixture to be placed on the market or
representative for mixtures present in the environment or food.
• For chemically fully deﬁned mixtures, the Scientiﬁc Committee recommends applying a
component-based approach, i.e. assessing all components individually using all available
information including read across and QSAR considerations about their genotoxic potential.
If a mixture contains one or more chemical substances that are assessed to be genotoxic in vivo via
a relevant route of administration, the mixture raises concern with respect to genotoxicity.
If the assessment of all components of a chemically fully deﬁned mixture results in the conclusion
that none of these raises a concern with respect to genotoxicity, the mixture is also considered of no
concern with respect to genotoxicity.
For mixtures that contain individual components indicating a potential concern for genotoxicity but
for which the data available are not sufﬁcient to conclude on genotoxicity, additional data would be
needed to complete an assessment.
If a mixture contains, besides chemically identiﬁed substances, a substantial fraction of chemical
substances that have not been chemically identiﬁed, the Scientiﬁc Committee recommends that, ﬁrst,
the chemically identiﬁed substances be assessed individually for their potential genotoxicity, using all
available information, including read across and QSAR considerations about their genotoxic potential.
If none of the identiﬁed chemical substances in a mixture raises concern for genotoxicity, the
genotoxic potential of the unidentiﬁed fraction should also be evaluated to complete the assessment of
the mixture. Experimental testing of the unidentiﬁed fraction should be considered as the ﬁrst option
or, if this is not feasible and a scientiﬁc justiﬁcation is provided, testing of the whole mixture should be
undertaken, following the Scientiﬁc Committee guidance for individual chemical substances (EFSA,
2011, 2017):
• If testing of the whole mixture or fractions containing the unidentiﬁed substances in an
adequately performed set of in vitro assays provides clearly negative results, the mixture
should be considered as of no concern with respect to genotoxicity and no further testing is
recommended.
• If testing of the whole mixture or fractions containing the unidentiﬁed substances in an
adequately performed battery of in vitro assays provides one or more positive results, an
in vivo follow-up study should be considered to assess the relevance of the ﬁndings for risk
assessment.
• For negative results in the in vivo follow-up tests of positive results in in vitro assays, the
relevance of the ﬁndings obtained in the in vivo follow-up tests will depend on the genetic
effect assessed (i.e. gene mutations, structural or numerical chromosomal aberrations or any
other effect), the test protocol applied (route of exposure, tissues, etc.) and expert judgement
on the reliability of the results obtained (including consideration of target tissue exposure).
• For positive results in the in vivo follow-up tests of positive results in in vitro assays, the
mixture does raise a concern about genotoxicity.
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Glossary and Abbreviations
Component-based approach An approach in which the risk of a group of chemical substances is
assessed based on exposure and effect data of its individual
components
GS Gas Chromatography
LC/MS liquid chromatography/mass spectrometry
limit of detection (LOD) Lowest concentration of a chemical substance in a deﬁned matrix in
which positive identiﬁcation can be achieved using a speciﬁed method
limit of quantiﬁcation (LOQ) Lowest concentration of a chemical substance in a deﬁned matrix in
which positive identiﬁcation and quantitative measurement can be
achieved using a speciﬁed analytical method
Margin of Exposure (MOE) Ratio of (a) a reference point of (eco)toxicity to (b) the theoretical,
predicted or estimated exposure dose or concentration
Mixture Any combination of two or more chemical substances, regardless of
source and spatial or temporal proximity that may contribute to effects
Mode of Action Biologically plausible sequence of key events leading to an observed
effect supported by robust experimental observations and mechanistic
data. It refers to the major steps leading to an adverse health effect
following interaction of the chemical substance with biological targets. It
does not imply full understanding of mechanism of action at the
molecular level
MRL maximum residue level
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QSAR quantitative structure–activity relationship
SAR structure–activity relationship
Substance A chemical element and its compounds in the natural state or obtained
by any manufacturing process, including any additive necessary to
preserve its stability and any impurity deriving from the process used,
but excluding any solvent that may be separated without affecting the
stability of the substance or changing its composition
Sum parameters Parameters determining the content of classes of chemical substances
with common structural aspects (e.g. phenols, proteins or reducing
sugars) rather than individual constituents
TTC Threshold of Toxicological Concern
Uncertainty A general term referring to all types of limitations in available knowledge
that affect the range and probability of possible answers to an
assessment question. Available knowledge refers here to the knowledge
(evidence, data, etc.) available to assessors at the time the assessment
is conducted and within the time and resources agreed for the
assessment. Sometimes uncertainty is used to refer to a source of
uncertainty and sometimes to its impact on the conclusion of an
assessment (EFSA, 2018).
UVCBs Substances of Unknown or Variable composition, Complex reaction
products or Biological materials
Whole mixture approach A risk assessment approach in which the mixture is treated as a single
entity, similar to single chemical substances and so requires dose–
response information for the whole mixture of concern
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